Rite Aid and Heritage Provider Network last month announced a new agreement to bring the Rite Aid Health Alliance program to HPN's chronic and polychronic patients in Southern California.
GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.
The use of FDA drug safety programs to prevent generic competition is costing the American health care system and patients $5.4 billion in annual pharmaceutical spending.
The Food and Drug Administration may have more generic drug applications than it does personnel to process them, according to a Wall Street Journal report published Tuesday.
SmartStory Technologies on Tuesday announced it has deployed its SmartStory enterprise platform, which automates the delivery of short, sequenced and personalized videos in several U.S. retail pharmacies.
A bipartisan bill that calls for a collaborative, coordinated approach to curbing prescription drug abuse and safeguarding patients is headed to the U.S. House for a vote.
Reckitt Benckiser announced the company will be looking to spin off its pharma business in the next 12 months.
The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.
The Food and Drug Administration has accepted a license application by Sandoz, Novartis' generics company, for a potential generic biologic drug, the company announced Monday.
The National Association of Specialty Pharmacy and the Specialty Pharmacy Association of America announced the merger of the two organizations, creating the largest professional and trade association focused on the unique needs in specialty pharmacy.